Back to All Events

'Signature Series' - The Future of Clinical Research: Where We are Heading and What It Means to You

This panel discussion on the future of the clinical research industry features perspectives from U.S. Food and Drug Administration, TransCelerate Biopharma, Inc., and site and CRO leadership. Gain an understanding of what the future might look like for clinical trials, how our panelists are preparing for that future, and how you can prepare yourself.

Featuring Our Expert Panel:

David Burrow, Acting Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Read Bio >>

David Burrow, Acting Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Read Bio >>

Jamie Macdonald , Chief Executive Officer, Parexel International  Read Bio >>

Jamie Macdonald , Chief Executive Officer, Parexel International
Read Bio >>

Dr. Dalvir Gill, PhD, Chief Executive Officer, TransCelerate BioPharma, Inc.  Read Bio >>

Dr. Dalvir Gill, PhD, Chief Executive Officer, TransCelerate BioPharma, Inc.
Read Bio >>

John P. Neal Chief Executive Officer, PCRS Network, LLC  Read Bio >>

John P. Neal Chief Executive Officer, PCRS Network, LLC
Read Bio >>